NSC |
Compound |
Enrichment |
Correlation |
NSC 673420 |
Null |
0.0247898374452139 |
-0.047120501 |
NSC 677598 |
Glutamamide, N-acetyl-1-O-(phenylmethyl)-.alpha.-normuramyl-prolyl- N(5)-[5-[(1-nitro-9-acridinyl)amino]pentyl]-, stereoisomer |
0.0247898374452139 |
0.31549141 |
NSC 678925 |
1-Phenazinecarboxamide, N-[2-(dimethylamino)ethyl]- 9-fluoro-, monohydrochloride |
0.0247898374452139 |
0.53829466 |
NSC 679001 |
2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl-, diethyl ester, (E)- |
0.0247898374452139 |
0.20746616 |
NSC 67925 |
Null |
0.0247898374452139 |
0.27139316 |
NSC 679800 |
Null |
0.0247898374452139 |
0.1980067 |
NSC 681239 |
Bortezomib |
0.0247898374452139 |
-0.16600813 |
NSC 682011 |
Benzimidazo[1,2-b]isoquinoline-6-carbonitrile, 7,8,9,10-tetrahydro-11-[(4-fluorophenyl)amino]- |
0.0247898374452139 |
0.13989821 |
NSC 690270 |
ANTINEOPLASTIC-690270 |
0.0247898374452139 |
0.064747457 |
NSC 691127 |
Null |
0.0247898374452139 |
0.29261061 |